Figure 7.
Recognition of DCs pulsed with NY-ESO-1 ICs by L9L-specific CD8+ T cells. ELISPOT assay with CD8+ T cells from patient ES-E03 presensitized with L9L and tested at day 12 against DCs cultured from HLA-A*0201+ healthy donor NC171.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.